Clinical endpoint - PDFSEARCH.IO - Document Search Engine

Clinical endpoint
Results: 228

#	Item
171	Clinical Studies Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Add to Reading List Source URL: www.fda.gov Language: English Science Pharmacology Design of experiments Epidemiology Medical statistics Surrogate endpoint Clinical trial Placebo-controlled study Food and Drug Administration Clinical research Research Medicine
172	Joint Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting March 10-11, 2010 Add to Reading List Source URL: www.fda.gov Language: English Safety Adolescence Health Asthma Respiratory therapy Clinical endpoint
173	Guidance for Industry ISE Add to Reading List Source URL: www.fda.gov Language: English Food and Drug Administration Clinical research Epidemiology Pharmacology Pharmaceutical industry Surrogate endpoint Center for Biologics Evaluation and Research Clinical trial New Drug Application Medicine Research Health
174	CCAC guidelines on: choosing an appropriate endpoint in experiments using animals for research, teaching and testing Add to Reading List Source URL: ccac.ca Language: English - Date: 2012-10-24 09:35:26 Animal welfare Pain Animal testing Medical research Animal model Pain in animals Animal euthanasia Canadian Council on Animal Care Clinical endpoint Biology Animal rights Zoology
175	DRAFT - FDA Questions for Circulatory System Devices Panel July 21st, 2011 H100004 - Berlin Heart EXCOR® Pediatric Ventricular Assist Device (VAD) 1. Primary Effectiveness Endpoint Results An HDE application must contai Add to Reading List Source URL: www.fda.gov Language: English Prosthetics Interventional cardiology Medical equipment Cardiology Ventricular assist device Extracorporeal membrane oxygenation Clinical trial Cohort Stroke Medicine Health Implants
176	Draft Agenda:[removed]INTERNAL USE ONLY Add to Reading List Source URL: www.fda.gov Language: English Center for Biologics Evaluation and Research Food and Drug Administration Influenza Surrogate endpoint Antivenom Medicine Health Clinical research
177	FDA Panel Questions 1 Safety The primary safety endpoint, the complication-free rate at 180-days post-implant, was assessed in all patients with an attempted S-ICD System implant. The 95% lower confidence bound was 97.9% Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Implants Cardiology Pharmaceutical industry Ventricular tachycardia Defibrillation International Statistical Classification of Diseases and Related Health Problems Clinical trial Food and Drug Administration Medicine Health Cardiac electrophysiology
178	Transcript: Public Workshop on Minimal Residual Disease (MRD) as a Surrogate Endpoint in Acute Myeloid Leukemia (AML) Add to Reading List Source URL: www.fda.gov Language: English Clinical trials Medical research Medical terms Minimal residual disease Acute myeloid leukemia Surrogate endpoint Medicine Acute leukemia Myeloid leukemia
179	Minimal Residual Disease (MRD) as a Surrogate Endpoint in Acute Myeloid Leukemia (AML) Workshop- March 4, 2013 DISCUSSION POINTS Add to Reading List Source URL: www.fda.gov Language: English Leukemia Minimal residual disease Acute myeloid leukemia Clinical trials Medical terms Surrogate endpoint Biomarker Medicine Acute leukemia Myeloid leukemia
180	Food and Drug Administration Add to Reading List Source URL: www.fda.gov Language: English Clinical trials Epidemiology Medical research Medical terms Pharmacology Surrogate endpoint Food and Drug Administration Antivenom Center for Biologics Evaluation and Research Medicine Health Clinical research

UPDATE